Vytorin, a drug used for lowering cholesterol levels, has been found to reduce the risk of heart disease among kidney patients by up to 25 percent, according to the results obtained by Oxford University research scientists who carried out the research on a group of 9,270 kidney disease patients, with the work starting in 2003.
The measured improvement was 17% but many patients were not on the
Subscribe to:
Post Comments (Atom)
Post a Comment